1. A review on the chemotherapeutic potential of fisetin: In vitro evidences
    Kiruthika Sundarraj et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  2. Fisetin suppresses migration, invasion and stem-cell-like phenotype of human non-small cell lung carcinoma cells via attenuation of epithelial to mesenchymal transition
    Saba Tabasum et al, 2019, Chemico-Biological Interactions CrossRef
  3. Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological tests
    Florence Lefranc et al, 2017, Seminars in Cancer Biology CrossRef
  4. Fisetin: A senolytic drug
    Asma Shafique et al, 2021, A Centum of Valuable Plant Bioactives CrossRef
  5. Knockdown of TWIST enhances the cytotoxicity of chemotherapeutic drugs in doxorubicin-resistant HepG2 cells by suppressing MDR1 and EMT
    Rong Li et al, 2018, International Journal of Oncology CrossRef
  6. Epithelial-mesenchymal transition as a target for botanicals in cancer metastasis
    Bahare Salehi et al, 2019, Phytomedicine CrossRef
  7. Exploring the molecular targets of dietary flavonoid fisetin in cancer
    Deeba N. Syed et al, 2016, Seminars in Cancer Biology CrossRef
  8. Dietary phytochemicals in the regulation of epithelial to mesenchymal transition and associated enzymes: A promising anticancer therapeutic approach
    Bornita Das et al, 2019, Seminars in Cancer Biology CrossRef
  9. Effect of Chinese Herbal Medicine Therapy on Overall and Cancer Related Mortality in Patients With Advanced Nasopharyngeal Carcinoma in Taiwan
    Chen-Yu Wang et al, 2021, Frontiers in Pharmacology CrossRef
  10. The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer
    Getinet M. Adinew et al, 2021, Nutrients CrossRef
  11. Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo
    Long‐Bin Jeng et al, 2018, Journal of Cellular Physiology CrossRef
  12. Evaluation of Anti-Metastatic Potential of the Combination of Fisetin with Paclitaxel on A549 Non-Small Cell Lung Cancer Cells
    Anna Klimaszewska-Wiśniewska et al, 2018, International Journal of Molecular Sciences CrossRef
  13. The Epstein–Barr virus LMP1 interactome: biological implications and therapeutic targets
    Mujeeb R Cheerathodi et al, 2018, Future Virology CrossRef
  14. Novel roles and therapeutic targets of Epstein–Barr virus-encoded latent membrane protein 1-induced oncogenesis in nasopharyngeal carcinoma
    Yongguang Tao et al, 2015, Expert Reviews in Molecular Medicine CrossRef
  15. Role of Fisetin in Chemosensitization
    Bokyung Sung, 2018, Role of Nutraceuticals in Chemoresistance to Cancer CrossRef
  16. The Natural Flavonoid Fisetin Inhibits Cellular Proliferation of Hepatic, Colorectal, and Pancreatic Cancer Cells through Modulation of Multiple Signaling Pathways
    Mаhmoud Youns et al, 2017, PLOS ONE CrossRef
  17. Molecular Mechanisms of Flavonoids against Tumor Gamma-Herpesviruses and Their Correlated Cancers—A Focus on EBV and KSHV Life Cycles and Carcinogenesis
    Sherif T. S. Hassan et al, 2022, International Journal of Molecular Sciences CrossRef
  18. Fisetin Inhibited Growth and Metastasis of Triple-Negative Breast Cancer by Reversing Epithelial-to-Mesenchymal Transition via PTEN/Akt/GSK3β Signal Pathway
    Jie Li et al, 2018, Frontiers in Pharmacology CrossRef
  19. Insights into intricacies of the Latent Membrane Protein-1 (LMP-1) in EBV-associated cancers
    Prankur Awasthi et al, 2023, Life Sciences CrossRef
  20. The epithelial–mesenchymal transition (EMT) is regulated by oncoviruses in cancer
    Xue Chen et al, 2016, The FASEB Journal CrossRef